Clinical trial
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
NCT04787510 is registered in ClinicalTrials.gov with University Hospital, Ioannina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
- Lead sponsor
- University Hospital, Ioannina
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 23, 2020
- Completion date
- June 23, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 disease, hospitalized patients, sars-cov2 infection